{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:59:34Z","timestamp":1780754374728,"version":"3.54.1"},"reference-count":68,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST111-2320-B-182-035-MY3"],"award-info":[{"award-number":["MOST111-2320-B-182-035-MY3"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NTSC114-2320-B-182-008"],"award-info":[{"award-number":["NTSC114-2320-B-182-008"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW113-CMAP-M-113-000002-D"],"award-info":[{"award-number":["MOHW113-CMAP-M-113-000002-D"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW114-CMAP-M-113-000005-C"],"award-info":[{"award-number":["MOHW114-CMAP-M-113-000005-C"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Integr Cancer Ther"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Triple-negative breast cancer (TNBC) is a major cause of mortality worldwide. Chinese herbal medicine (CHM) is often used as adjunctive therapy, but its long-term impact on TNBC remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>This study analyzed a multi-institutional cohort from the Chang Gung Research Database, investigating long-term outcomes of integrative CHM use in TNBC patients newly diagnosed between January 1, 2011, and December 31, 2021. Patients were followed for up to 10\u2009years or until death. Overall survival rate (OS) and disease-specific survival rates were assessed using Kaplan\u2013Meier estimation with overlap weighting and landmark analysis to reduce bias. Core CHMs were identified through network pharmacology analysis on prescriptions made for TNBC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The analysis included 2174 TNBC patients, with 464 using CHM. CHM use was associated with a significantly higher 10-year OS compared to non-users (77.7% vs 70.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.007). In stages 1 to 3, the OS among CHM users was 6.6% higher (80.7% vs 74.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.018). After adjusting for demographic factors, CHM use reduced the risk of all-cause mortality (adjusted hazard ratio [aHR]: 0.71,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.044). Lower disease-specific survival rates were observed among CHM users. Core CHMs, such as\n                      <jats:italic toggle=\"yes\">Hedyotis diffusa Willd.<\/jats:italic>\n                      , may have potential anti-cancer effects, while combinations like Jia-Wei-Xiao-Yao-San,\n                      <jats:italic toggle=\"yes\">Scutellaria barbata<\/jats:italic>\n                      D. Don. and Suan-Zao-Ren-Tang may have a complementary role to standard treatments for TNBC.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Use of CHM may improve 10-year OS in TNBC patients, and core CHMs provided crucial references for further studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15347354261451843","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:24:45Z","timestamp":1780572285000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Chinese Herbal Medicine as Adjuvant Management for Triple-Negative Breast Cancer: A Multi-Institutional Real-World Study With Mechanism Exploration"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4671-4845","authenticated-orcid":false,"given":"Hsiang-I","family":"Hou","sequence":"first","affiliation":[{"name":"Chang Gung Memorial Hospital, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsu-Huan","family":"Chou","sequence":"additional","affiliation":[{"name":"Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wei","family":"Lee","sequence":"additional","affiliation":[{"name":"Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-9851","authenticated-orcid":false,"given":"Hsing-Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Chang Gung Memorial Hospital, Taoyuan, Taiwan"},{"name":"Chang Gung University, Taoyuan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20211033"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.2196\/17084"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-015-3859-y"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1001389"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22618"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1935-y"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-04316-2"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13428-2"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4147"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072113"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2015.01019"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2011.04.001"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1819794"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000001019"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Sun X Zhang X Nian JY et al. Chinese herbal medicine as adjunctive therapy to chemotherapy for breast cancer: a systematic review and meta-analysis. Evid Based Complement Altern Med. 2016;2016:3281968.","DOI":"10.1155\/2016\/3281968"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/15347354231178898"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2020.102456"},{"key":"e_1_3_2_20_2","article-title":"Effectiveness of the Sanyin formula plus chemotherapy on survival in women with triple-negative breast cancer: a randomized controlled trial","volume":"12","author":"Wu C","year":"2022","unstructured":"Wu C, Sun C, Liu G, et al. Effectiveness of the Sanyin formula plus chemotherapy on survival in women with triple-negative breast cancer: a randomized controlled trial. Front Oncol. 2022;12:850155.","journal-title":"Front Oncol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v12.i20.4074"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4713"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v13.i5.476"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2017.08.002"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-015-4869-5"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S106017"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13924"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/lary.26691"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002985"},{"issue":"1","key":"e_1_3_2_30_2","article-title":"What is recall bias?","volume":"344","author":"Sedgwick P.","year":"2012","unstructured":"Sedgwick P. What is recall bias? BMJ. 2012;344(1):e3519-e3519.","journal-title":"BMJ"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2015.12.012"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.5208"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwac043"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.7819"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2015.04.002"},{"key":"e_1_3_2_36_2","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero J","year":"2020","unstructured":"Pi\u00f1ero J, Ram\u00edrez-Anguita JM, Sa\u00fcch-Pitarch J, et al. The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 2020;48(D1):D845-D855.","journal-title":"Nucleic Acids Res"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1005968"},{"key":"e_1_3_2_38_2","article-title":"A human functional protein interaction network and its application to cancer data analysis","author":"Wu G","unstructured":"Wu G, Feng X, Stein L. A human functional protein interaction network and its application to cancer data analysis. Genome Biol. 2010\/05\/19;11(5):R53. 2010.","journal-title":"Genome Biol"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1559-2"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.2196\/27614"},{"key":"e_1_3_2_41_2","article-title":"The association between mortality and use of Chinese herbal medicine among incident stage IV esophageal cancer patients: a retrospective cohort study with core herbs exploration","volume":"13","author":"Chen SL","year":"2022","unstructured":"Chen SL, Lin WC, Chen YC, et al. The association between mortality and use of Chinese herbal medicine among incident stage IV esophageal cancer patients: a retrospective cohort study with core herbs exploration. Front Pharmacol. 2022;13:1018281.","journal-title":"Front Pharmacol"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1145\/1556460.1556497"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-9-192"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.1414"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-011-0211-9"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-016-4059-6"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2010.05.018"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01296-5"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2018.09.004"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2022.2023011"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.04.014"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.112929"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02967457"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14697"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.2174\/0113894501265851240102101122"},{"key":"e_1_3_2_56_2","article-title":"Mechanistic exploration of traditional Chinese medicine regulation on tumor immune microenvironment in the treatment of triple-negative breast cancer: based on CiteSpace and bioinformatics analysis","volume":"15","author":"Feng D","year":"2024","unstructured":"Feng D, Pu D, Ren J, et al. Mechanistic exploration of traditional Chinese medicine regulation on tumor immune microenvironment in the treatment of triple-negative breast cancer: based on CiteSpace and bioinformatics analysis. Front Immunol. 2024;15:1443648.","journal-title":"Front Immunol"},{"key":"e_1_3_2_57_2","article-title":"Prescription pattern of Chinese herbal products for breast cancer in taiwan: a population-based study","author":"Lai JN","year":"2012","unstructured":"Lai JN, Wu CT, Wang JD. Prescription pattern of Chinese herbal products for breast cancer in taiwan: a population-based study. Evid Based Complement Alternat Med. 2012:891893.","journal-title":"Evid Based Complement Alternat Med"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/202378"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1177\/15347354221150907"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/803239"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.599073"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.18433\/J3RC77"},{"issue":"1","key":"e_1_3_2_63_2","first-page":"95","article-title":"Cellular mechanisms of multidrug resistance of tumor cells","volume":"65","author":"Stavrovskaya AA.","year":"2000","unstructured":"Stavrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry (MOSC). 2000;65(1):95-106.","journal-title":"Biochemistry (MOSC)"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6137059"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.120.000050"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1177\/15347354231162080"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202809"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.674354"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01595-6"}],"container-title":["Integrative Cancer Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15347354261451843","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15347354261451843","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15347354261451843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:16:35Z","timestamp":1780751795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15347354261451843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":68,"alternative-id":["10.1177\/15347354261451843"],"URL":"https:\/\/doi.org\/10.1177\/15347354261451843","relation":{},"ISSN":["1534-7354","1552-695X"],"issn-type":[{"value":"1534-7354","type":"print"},{"value":"1552-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"15347354261451843"}}